JP Patent

JP5136586B2 — 通信装置、通信方法、および通信プログラム

Assigned to Brother Industries Ltd · Expires 2013-02-06 · 13y expired

What this patent protects

Patent listed against Cleviprex.

Drugs covered by this patent

Patent Metadata

Patent number
JP5136586B2
Jurisdiction
JP
Classification
—
Expires
2013-02-06
Drug substance claim
No
Drug product claim
No
Assignee
Brother Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.